Editorial board

Brian Tempest Hale & Tempest Co Ltd., UK

Ranjit Barshikar Quality by Design / cGMP, India
Paul Braier Greenblum & Bernstein PLC, USA
Nicholas Cappuccino Pharmaceutical Intellectual Resource Services LLC, USA
Carlos M. Correa University of Buenos Aires, Argentina
Dolores Cullen MFJ International, USA
Sanjeev Dani Aurobindo Pharma, India
Marcel Daniels Teva Pharmaceutical Industries Ltd, Belgium
Debashis Dasgupta Kent Pharmaceuticals, UK
Richard L. DiCicco Technology Catalysts International, USA
Eric B. Fastiff Lieff Cabraser Heimann & Bernstein, USA
Thomas Faunce Australian National University, Australia
Rahul Garella Strides, Europe
Biju Jacob Strides, UAE
Sudarshan Jain IPA Secretary General, India and Asia (excluding Japan)
Gordon Johnston Generic Pharmaceutical Association, USA
Fabiana Jorge MFJ International, USA
Sandeep Juneja TB Alliance, USA
Yahudah Livneh VP Corporate IP & Legislative Affairs, Israel
Yehudah Livneh Livneh Associates, Israel
Kate Lynch Generic Medicines Industry Association Pty Ltd, Austrialia
Richard Milchior Herald Avocats, France
Vijay Raghavan Sandoz, Switzerland
Sandeep K. Rathod USV Private Limited, India
Juichi Riku Consultant, Japan
Paolo Romangnoli Pharmaceutical Chemicals, Italy
Sol Ruiz Spanish Medicines Agency (AEMPS), Spain
Enrique Seoane-Vasquez Massachusetts College of Pharmacy and Health Sciences, USA
Abhishek Sharma Jefferies, India
Steven Simoens Catholic University of Leuven, Belgium
Lawrence Yu University of Michigan, USA
Keith A. Zullow Partner, Goodwin Procter LLP, USA